STAAR Surgical Company (STAA) — Fair Value Analysis

Base-case fair value (P50): $26.27 · Current price: $26.18 · Verdict: Fairly Valued

The Verdict on STAA

STAAR SURGICAL (STAA) appears Fairly Valued based on our latest Monte Carlo simulations, which project a median fair value (P50) of $26.27. With the stock currently trading at $26.18, this suggests a nominal +0.3% to its P50 target. While this indicates STAA is not significantly over or undervalued at present, investors should consider the broader implications of its unrated quality tier, which limits immediate insight into its operational and financial health compared to its sector peers. Our analysis, drawing on thousands of forward scenarios, pegs the current price very close to the simulated median fair value.

How STAA stacks up against peers

Given STAA’s unrated quality tier, a direct comparative assessment against sector peers is currently constrained. The absence of a formal rating on its operational and financial health means investors lack a key benchmark to contextualize the current trading level of $26.18 relative to industry standards. This contrasts with companies where a defined quality tier can inform whether the current price reflects superior or inferior fundamentals. Although our Monte Carlo simulations identify a median fair value of $26.27, the unrated status emphasizes the importance of independent due diligence beyond just the numerical valuation, particularly when considering the modest +0.3% indicated.

What this means for investors

Investors evaluating STAA should note the Fairly Valued assessment, with our simulations placing its $26.18 very close to the median fair value of $26.27. The +0.3% indicates a neutral near-term outlook based purely on the P50 target. While the current price hovers near its median fair value, the unrated quality tier implies a heightened need for investors to conduct their own fundamental analysis. Considering STAA is presently at a fair juncture, monitoring its trajectory through various market conditions becomes crucial. To fully grasp STAA's potential downside scenario and bull case, including the broader probabilistic distribution, sign up for a free FairCurve account. This will allow you to track STAA's fair value as new fundamentals are released and see the full Monte Carlo distribution.